Orchid Pharma Limited has informed the Exchange in relation to theentering into a Joint Memo of Compromise with DBS Bank India Limited

Orchid Pharma has entered into a Joint Memo of Compromise with DBS Bank India Limited, indicating a negotiated settlement or restructuring of its outstanding debt obligations with the bank. A Joint Memo of Compromise is typically used when a borrower and lender agree to revised terms to resolve dues, often involving a reduction in principal, interest waiver, or extended repayment schedule. The filing signals that Orchid Pharma and DBS Bank have mutually agreed on terms outside of standard loan repayment. Specific financial details of the compromise — such as the quantum of debt involved or revised terms — have not been disclosed in this filing.